Emerging Research

AML Roundtable: New Developments & Patient Access

Leading acute myeloid leukemia (AML) experts discuss new developments in AML research from ASH 2020 and the importance of patient access.

Courtney DiNardo, M.D., MSCE, Eunice Wang, MD, Jessica Altman, MD, Andrew Schorr

What Gene is Driving My Cancer?

Dr. Drilon explains the importance of genomic testing for cancer and how understanding the dna of the cancer affects treatment.

Alexander Drilon, MD, Andrew Schorr

Latest News

When Will We Have Safer and More Effective AML Treatments?

Are Blood Cancers Hereditary?

Andrew Schorr, Courtney DiNardo, M.D., MSCE

What Does The Viale-A Study Mean For Older AML Patients?

Andrew Schorr, Courtney DiNardo, M.D., MSCE

New Study May Revolutionize the Way We Detect Cancer

AML News to Discuss With Your Doctor

Naveen Pemmaraju, MD, Andrew Schorr

Genetic Research Leads to Progress in Survival Statistics

Tapan M. Kadia, MD, Andrew Schorr

AML Treatment Developments: Key Takeaways From ASH 2018

Naval G. Daver, MD

Emerging Research and Promising AML Treatment Approaches

Leah Szumita, MS, RN, Steve Buechler, Naval G. Daver, MD

Clinical advances in acute myeloid leukemia

Dr Christoph Röllig